Recently@Retina

September 2023

The mission of the Retina Foundation of the Southwest is to prevent vision loss and restore sight through innovative research and treatment for pediatric eye conditions, inherited eye diseases, and age-related macular degeneration.

— LATEST NEWS & EVENTS —

The Retina Foundation is proud to share that CEO and Chief Medical Officer Dr. Karl Csaky has been named as a finalist for Outstanding Healthcare Innovator for D CEO’s 2023 Excellence in Healthcare Awards. As a vitreoretinal specialist and expert in age-related macular degeneration (AMD), Dr. Csaky leads the Retina Foundation’s mission to provide innovative and patient-focused solutions in less time than traditional research institutions to preserve and restore vision. Dr. Csaky is focused on cutting-edge research to make breakthroughs and discover personalized treatment solutions through gene therapy, state-of-the-art stem cell research and clinical studies for numerous novel therapies. Please join us in congratulating Dr. Csaky on this recognition!

D CEO: Finalists Announced: D CEO’s 2023 Excellence in Healthcare Awards – D Magazine

Dallas Innovates: 3 North Texas Innovators in the Spotlight as D CEO Healthcare Award Finalists » Dallas Innovates

Thank You for Making NTx

Giving Day a Success!

We raised over $50,000

A little goes a long way when North

Texans give all at once.

www.NorthTexasGivingDay.org/organization/Retina- Foundation-Of-The-Southwest

Focus on Researchers@Retina

Eric Vasquez joined the Molecular Ophthalmology laboratory at the Retina Foundation as a Clinical Research Coordinator in January 2023. A native Tejano of Mexican descent, he was born and raised in a small town in northeast Texas.

Eric is a first-generation student/college graduate earning his degrees from the University of Texas at Austin in Biochemistry and Psychology in 2021. Throughout his undergrad, he discovered an interest in degenerative diseases and made Alzheimer’s disease the topic for many of his research essays. At the same time, his father had been diagnosed with early-onset Alzheimer’s and eventually passed away in 2020. Eric states his father was one of his biggest motivators for working in research to help find cures for debilitating diseases such as Alzheimer’s and Age-Related Macular Degeneration. Eric continues his work coordinating studies and cares deeply for his research participants.

Eye on the Cure Podcast Episode 53: David Birch, PhD

David G. Birch, PhD talks to Foundation Fighting Blindness Eye On the Cure podcast host, Ben Shaberman about his productive and impactful 40-plus-year career as a retinal disease researcher and clinical trial investigator. Dr. Birch also discusses the challenges and opportunities for advancing more therapies through trials and getting those therapies out to the people who need them.

https://soundcloud.com/fndfightingblindness/eye-on-the-cure-podcastepisode-53-david-birch-phd

Enjoy an artistic and unique evening.

A collection of art and apparel by Kathryn Iklé will be on display and for sale, with a percentage of all sales donated to The Retina Foundation to aid in the fight against blindness.

https://www.kathrynikle.com/artexhibit2023.html

Recent Clinical Trials @ Retina

A Phase 1 Study to Evaluate the Safety and Tolerability of a New Therapeutic for Retinal Dystrophy

Rose-Silverthorne Laboratory

ClinicalTrials.gov ID: NCT05902962

A study to evaluate the safety and tolerability of IV-administered VP-001 in participants with confirmed PRPF31 mutation-associated Retinal Dystrophy.

A Phase 1/2 Study to Assess the Safety and Efficacy of OCU410 for Geographic Atrophy Secondary to Dry AMD

Molecular Ophthalmology Laboratory

ClinicalTrials.gov ID: NCT06018558

A study to evaluate a sterile ophthalmic suspension for subretinal injection. The product, a modifier gene therapy platform, is a new way of addressing a genetic disease arising through a multitude of genetic mutations in various genes.

Please help the Retina Foundation continue ​leading research and saving sight.